32 studies found for:
Open Studies | Type 1 Diabetes | Denmark
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Not yet recruiting |
Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes Mellitus
|
||||
| 2 | Unknown † |
The Effect of Metformin in Overweight Patients With Dysregulated Type 1 Diabetes Mellitus
|
||||
| 3 | Recruiting |
Liraglutide in Type 1 Diabetes
|
||||
| 4 | Recruiting |
Effect of CSII and CGM on Progression of Late Diabetic Complications
|
||||
| 5 | Recruiting |
A Trial Investigating the Effect of Acute Hypoglycaemia on Cognitive Function and Brain Activation Patterns in Subjects With Type 1 Diabetes
|
||||
| 6 | Recruiting |
REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
|
||||
| 7 | Not yet recruiting |
A Study of LY2605541 and Glargine on Fats in Participants With Type 1 Diabetes
|
||||
| 8 | Recruiting |
The Effect of GLP-1 on the Inhibition of Glucagon Secretion
|
||||
| 9 | Not yet recruiting |
Acute Exercise and Glucotoxicity
|
||||
| 10 | Not yet recruiting |
User Evaluation of the MiniMed 620G Insulin Pump
|
||||
| 11 | Recruiting |
Recurrent Hypoglycaemia in Type 1 Diabetes
|
||||
| 12 | Recruiting |
A Pilot Study of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
|
||||
| 13 | Not yet recruiting |
Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy
|
||||
| 14 | Not yet recruiting |
Diameter Changes of Retinal Vessels During Hypoxia
|
||||
| 15 | Recruiting |
GIP and GLP-1 in Type 1 Diabetes
|
||||
| 16 | Not yet recruiting |
Collection of Performance Data From the Integrated Sensor and Infusion Set. TRIAL 4
|
||||
| 17 | Recruiting |
Vasodilatatory and Metabolic Effects of Glucagon-like Peptide-1 in Perphery Circulation in Patients With and Without Type 2 Diabetes Mellitu
|
||||
| 18 | Recruiting |
The Effect of Type 2 Diabetes and Dietary Regulation on VLDL1-and VLDL2-triglyceride Metabolism
|
||||
| 19 | Recruiting |
The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes
|
||||
| 20 | Unknown † |
GPR 119 Stimulated GLP-1 Secretion
|
† Indicates status has not been verified in more than two years
